ASX Growth Leaders With High Insider Ownership July 2026
As the Australian market edges towards a modest gain, buoyed by Wall Street's resilience despite global tensions and fluctuating commodity prices, investors are keenly observing growth companies with strong insider ownership as potential opportunities. In such a climate, businesses where insiders hold significant stakes can often indicate confidence in long-term prospects, making them noteworthy contenders for those seeking to navigate the current economic landscape.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Torque Metals (ASX:TOR) | 18.9% | 94.2% |
| Starpharma Holdings (ASX:SPL) | 21.8% | 91.8% |
| SKS Technologies Group (ASX:SKS) | 28.2% | 42.5% |
| Predictive Discovery (ASX:PDI) | 10.4% | 65.1% |
| Pinnacle Investment Management Group (ASX:PNI) | 25% | 21.2% |
| Forrestania Resources (ASX:FRS) | 31.9% | 126.7% |
| Austral Resources Australia (ASX:AR1) | 20% | 38.7% |
| Auric Mining (ASX:AWJ) | 19.6% | 29.2% |
| Adveritas (ASX:AV1) | 17.6% | 108.4% |
| Advanced Engineered Materials (ASX:AEM) | 35.1% | 48.5% |
Let's uncover some gems from our specialized screener.
Aurelia Metals (ASX:AMI)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Aurelia Metals Limited is an Australian company focused on the exploration and production of mineral properties, with a market capitalization of A$558.82 million.
Operations: Aurelia Metals generates revenue through its exploration and production activities in the mineral sector within Australia.
Insider Ownership: 28.2%
Earnings Growth Forecast: 21.3% p.a.
Aurelia Metals demonstrates potential as a growth company with high insider ownership, highlighted by its forecasted earnings growth of 21.3% annually, surpassing the Australian market average. The company's revenue is expected to grow at 7.4% per year, outpacing the broader market. Recent board changes include the return of Lyn Brazil as a Non-Executive Director, adding strategic insight and investment acumen. Trading at 43.5% below fair value estimates suggests attractive valuation prospects for investors seeking growth opportunities in Australia.
- Click to explore a detailed breakdown of our findings in Aurelia Metals' earnings growth report.
- According our valuation report, there's an indication that Aurelia Metals' share price might be on the cheaper side.
Cobram Estate Olives (ASX:CBO)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Cobram Estate Olives Limited is involved in the production and marketing of olive oil across Australia, the United States, and international markets, with a market cap of A$1.58 billion.
Operations: The company's revenue segments consist of A$60.80 million from US operations and A$177.63 million from Australian operations.
Insider Ownership: 13.3%
Earnings Growth Forecast: 22.2% p.a.
Cobram Estate Olives is poised for significant growth, with revenue expected to increase by 35.1% annually, outpacing the Australian market. Its earnings are forecast to grow at 22.2% per year, reflecting robust potential despite a low future return on equity of 9.5%. Trading at 77.1% below estimated fair value indicates attractive valuation prospects. Recent board changes include Daniel Masters' appointment as a non-executive director, enhancing strategic oversight following the acquisition of California Olive Ranch Inc.
- Click here and access our complete growth analysis report to understand the dynamics of Cobram Estate Olives.
- Our comprehensive valuation report raises the possibility that Cobram Estate Olives is priced higher than what may be justified by its financials.
Regis Healthcare (ASX:REG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Regis Healthcare Limited provides residential aged care services in Australia and has a market cap of A$1.84 billion.
Operations: The company generates revenue of A$1.26 billion from its residential aged care, home care, and retirement living services in Australia.
Insider Ownership: 38.6%
Earnings Growth Forecast: 19.2% p.a.
Regis Healthcare is positioned for growth, with earnings expected to increase by 19.2% annually, surpassing the Australian market's forecast. Despite negative shareholder equity and a dividend not well covered by earnings, the company trades at 78.9% below its estimated fair value. Recent insider activity shows more shares sold than bought over three months. The retirement of CFO Rick Rostolis marks a leadership shift as Regis prepares for future expansion initiatives.
- Delve into the full analysis future growth report here for a deeper understanding of Regis Healthcare.
- Insights from our recent valuation report point to the potential undervaluation of Regis Healthcare shares in the market.
Next Steps
- Unlock our comprehensive list of 101 Fast Growing ASX Companies With High Insider Ownership by clicking here.
- Searching for a Fresh Perspective? These 26 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com